Adenoviral vectors for gene transfer
Authors:
- Imre KovesdiIKImre Kovesdi
- Douglas E BroughDBDouglas E Brough
- Joseph T BruderJBJoseph T Bruder
- Thomas J WickhamTWThomas J Wickham
- 1 October 1997
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 8 (5) , 583-589
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapyGene Therapy, 1997
- Characterization of Factors Involved in Modulating Persistence of Transgene Expression from Recombinant Adenovirus in the Mouse LungHuman Gene Therapy, 1997
- Development of Cell Lines Capable of Complementing E1, E4, and Protein IX Defective Adenovirus Type 5 MutantsHuman Gene Therapy, 1995
- Pulmonary Inflammation Induced by Incomplete or Inactivated Adenoviral ParticlesHuman Gene Therapy, 1995
- FK506 Immunosuppression to Control the Immune Reactions Triggered by First-Generation Adenovirus-Mediated Gene TransferHuman Gene Therapy, 1995
- Prolonged Transgene Expression in Cotton Rat Lung with Recombinant Adenoviruses Defective in E2aHuman Gene Therapy, 1994
- Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosisNature Genetics, 1994
- Replicating vectors for gene therapy of cancer: risks, limitations and prospectsEuropean Journal of Cancer, 1994
- Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachmentCell, 1993
- Role of Adenovirus Antigens in the Induction of Virus Neutralizing AntibodyJournal of General Virology, 1968